Health Care: Drugs

Lexicon Pharmaceuticals Inc (LXRX: NASDAQ)

$14.22 -0.07 | -0.49%
03/23/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 83.34M 130.01M 22.85M 2.22M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 83.34M 130.01M 22.85M 2.22M
Selling, General, and Administrative Expenses 43.04M 23.84M 19.41M 17.12M
Research & Development 178.15M 95.19M 89.28M 89.68M
Operating Income before D & A (EBITDA) -137.86M 10.99M -85.84M -104.58M
Depreciation & Amortization 2.58M 1.25M 2.03M 2.86M
Interest Income 2.29M 572.00K 2.25M 216.00K
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 703.00K -9.52M -14.53M 2.21M
Total Income Before Interest Expenses (EBIT) -137.44M 793.00K -100.14M -105.02M
Interest Expense 6.57M 6.72M 2.25M 1.97M
Pre-Tax Income -144.01M -5.93M -102.39M -106.99M
Income Taxes 0.00 0.00 -70.00K 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -141.43M -4.68M -100.29M -104.13M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -141.43M -4.68M -100.29M -104.13M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -141.43M -4.68M -100.29M -104.13M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-142.13M 4.84M -85.76M -106.34M
Preferred Dividends
Net Income Available To Common -141.43M -4.68M -100.29M -104.13M
Basic EPS from Continuing Ops. -1.36 -0.05 -1.31 -1.42
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.36 -0.05 -1.31 -1.42
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.36 -0.05 -1.31 -1.42
Basic Normalized Net Income/Share -1.37 0.05 -1.12 -1.45
EPS fr Continuing Ops. -1.36 -0.05 -1.31 -1.42
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.36 -0.05 -1.31 -1.42
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.36 -0.05 -1.31 -1.42
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.37 0.05 -1.12 -1.45
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with LXRX

Latest LXRX Headlines from TheStreet

More Financial News for LXRX

Press Releases for LXRX

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter